Patent application number | Description | Published |
20080260857 | Substance and Method for Treating Neoplasms - The invention relates to substance and method for treating neoplasms in mammals. A substance for treating neoplasm comprises water comprising from 99.76 to 99.99 molecular % of light isotopologue | 10-23-2008 |
20080292718 | Method for Suppression Appetite and Food Intake - The invention relates to method for suppressing appetite and food intake in a mammal in need thereof comprising a step of administering to said mammal an effective amount of water comprising from 99.76 to 99.99 molecular % of isotopologue | 11-27-2008 |
20080292719 | Method of Treating Metabolic Syndrome - The invention relates to the method of treating metabolic syndrome in a mammal in need thereof comprising a step of administering to said mammal an effective amount of water comprising from 99.76 to 99.99 molecular % of isotopologue | 11-27-2008 |
20080299221 | Method for Decreasing Postprandial Glucose Excursion - The invention relates to the method for decreasing postprandial glucose excursion in a mammal in need thereof comprising a step of administering to said mammal an effective amount of water comprising from 99.76 to 99.99 molecular % of isotopologue | 12-04-2008 |
20090175955 | HYDROPEROXYLAPATITE AND COMPOSITIONS THEREOF - This invention relates to a compound of general formula Ca | 07-09-2009 |
20090263350 | COSMETIC AND DERMATOLOGICAL METHODS - The present invention relates to cosmetic and dermatological methods for treating cellulite, reducing signs of aging skin, and treating stretch marks, the methods comprising applying/administering to the skin of a subject in need thereof the compositions comprising interleukin-1 alpha. | 10-22-2009 |
20100144773 | PHARMACEUTICAL COMPOSITIONS FOR INTRANASAL ADMINISTRATION COMPRISING CHOLINE SALTS OF SUCCINIC ACID - The present invention relates to pharmaceutical compositions for the intranasal administration comprising a therapeutically effective amount of a compound of formula (I) or pharmaceutically acceptable salts thereof. Preferably, the pharmaceutically acceptable salt is selected from the group consisting of choline salt, sodium salt, potassium salt, and thiamine salt. Further, the present invention relates to methods for intranasal delivering compound of formula (I) and pharmaceutically acceptable salts thereof. Further, the present invention relates to methods for treating a neurodegenerative disease with using compositions of the present invention. | 06-10-2010 |
20100160440 | INTRANASAL PHARMACEUTICAL COMPOSITIONS COMPRISING SUCCINIC ACID AND METHODS THEREOF - The present invention relates to intranasal pharmaceutical compositions for preventing and/or treating a disease selected from the group consisting of Alzheimer's disease, Parkinson's disease, cerebral ischemia and neurological damage due to stroke comprising a therapeutically effective amount of succinic acid or a pharmaceutically acceptable salt thereof, and a pharmaceutically and intranasally acceptable carrier. Further, the present invention relates to methods for preventing and/or treating a disease selected from the group consisting of Alzheimer's disease, Parkinson's disease, cerebral ischemia and neurological damage due to stroke with using compositions of the present invention. | 06-24-2010 |
20100259888 | THERMAL SPREADER FOR HEAT PIPE COOLERS AND WATER COOLERS - This invention relates to thermal spreader incorporated into heat pipe coolers and water coolers for electronic components, said spreader having optimal aspect ratio T/(√S)≧0.17 to provide optimal parameters of thermal resistance and lowering noise created by these coolers supplying by operating fans, where T is thickness of said thermal spreader and (√S) is square root of the surface area of the first surface of said thermal spreader. Further, the invention relates to electronic systems comprising said thermal spreader with optimal aspect ratio T/(√S)≧0.17 to provide better thermal management of electronic components incorporated into these electronic systems. | 10-14-2010 |
20110189126 | COMPOSITIONS CONTAINING INTERLEUKIN-1 AND PEPTIDES - The present invention relates to pharmaceutical, dermatological, cosmeceutical, or cosmetic compositions comprising (a) interleukin-1 family members consisting of interleukin-1 alpha, interleukin-1 family member 5 (delta), interleukin-1 family member 6 (epsilon), interleukin-1 family member 7 (zeta), interleukin-1 family member 8 (eta), interleukin-1 family member 9, interleukin-1 family member 10 (theta), and interleukin-18; (b) a peptide of the general formula (I): Tyr-X | 08-04-2011 |
20110237668 | CHOLINE SALTS OF SUCCINIC ACID FOR THE TREATMENT OF DEPRESSION, ANXIETY, SCHIZOPHRENIA, SLEEP DISORDER, AND EPILEPSY - The present invention relates to compositions and methods for treatment of depression, anxiety, schizophrenia, sleep disorder, or epilepsy comprising monocholine salt of succinic acid of a formula (I) or a pharmaceutically acceptable salt thereof. Preferably, the pharmaceutically acceptable salt is dicholine salt of succinic acid of a formula (II). | 09-29-2011 |
20120219511 | ORAL CARE COMPOSITIONS CONTAINING HUMAN RECOMBINANT INTERLEUKIN-1 - The present invention relates to oral care compositions comprising human recombinant interleukin-1 and methods thereof for keeping the oral cavity in a good condition, reducing oral malodor, and/or preventing or treating periodontal diseases. Preferably, the human recombinant interleukin-1 is human recombinant interleukin-1 alpha or beta. | 08-30-2012 |
20120270908 | SUBSTITUTED 3 -HYDROZYPYRIDINES AND PHARMACEUTICAL COMPOSITIONS THEREOF - Therapeutic compounds of formula (I) wherein R1 is selected from the group consisting of C | 10-25-2012 |
20130078268 | VACCINE COMPOSITIONS AND METHODS OF USE THEREOF - The present invention relates to vaccine composition and methods for eliciting a protective immune response in animals against an endogenous peptide of the formula pGlu-Pro-Pro-Gly-Gly-Ser-Lys-Val-Ile-Leu-Phe, the composition comprising an immunizing effective amount of said peptide or conjugates thereof. Further, the invention relates to methods of treating cancer, cardiovascular diseases, and increasing life span in an animal, the methods comprising a step of administering to the animal of the vaccine composition of the invention. | 03-28-2013 |
20140154258 | PHARMACEUTICAL COMPOSITIONS CONTAINING ANTIBODIES TO NEUROPEPTIDE HEAD ACTIVATOR AND METHODS THEREOF - This invention relates to pharmaceutical compositions comprising antibodies that specifically bind to the endogenous neuropeptide head activator (NHA) having the sequence of pGlu-Pro-Pro-Gly-Gly-Ser-Lys-Val-Ile-Leu-Phe and neutralize the function of NHA thereby. The invention also provides methods for neutralizing NHA function, and particularly for treating NHA-related disorders (e.g., cancer or cardiovascular diseases) by administering to mammals of the pharmaceutical compositions. | 06-05-2014 |